Genentech
XOLAIR
Manufacturer:
Genentech
Name:
XOLAIR
HCPCS Code Descriptor:
Injection, omalizumab, 5 mg
Category:
J Code
HCPCS:
J2357
NDC(s):
50242-0214-01, 50242-0215-01, 50242-0040-62
Primary Type:
Anti-Eosinophil Asthma
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
XOLAIR is an Anti-Eosinophil Asthma drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J2357 is aligned to the drug XOLAIR.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/05
HCPCS Effective Date:
1/1/05
HCPCS Short Description:
Omalizumab injection
Billing and Coding Guide:
https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/XOLAIR-Billing-Coding-for-Chronic-Spontaneous-Urticaria.pdf
Patient Assistance:
Not Found